SCHEMBL7026100

SCHEMBL7026100

Fc1ccccc1CCN1CCC(Sc2cccc(Cl)n2)CC1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.48
CYP1A2 P05177 1/20 0.48
KMT2A Q03164 1/20 0.48
HTR2A P28223 5/20 0.41
GRM2 Q14416 1/20 0.40
OPRK1 P41145 2/20 0.39
KCNH2 Q12809 4/20 0.38
MAOB P27338 2/20 0.38
MAOA P21397 1/20 0.38
CACNA1G O43497 1/20 0.37
CCR4 P51679 1/20 0.37
DRD2 P14416 3/20 0.36
HTR2C P28335 2/20 0.36
HRH1 P35367 1/20 0.36
CARM1 Q86X55 1/20 0.36
PRMT6 Q96LA8 1/20 0.36
OPRM1 P35372 2/20 0.36
OPRD1 P41143 1/20 0.36
HTR1A P08908 1/20 0.35
SLC6A4 P31645 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7021838 0.86 MEN1 (0.48) MEN1CYP1A2KMT2AKCNH2CARM1
SCHEMBL7031546 0.86 MEN1 (0.45) MEN1CYP1A2KMT2AHTR2AKCNH2
SCHEMBL7025728 0.83 MEN1 (0.49) MEN1CYP1A2KMT2AHTR2AKCNH2
SCHEMBL7035228 0.77 MEN1 (0.48) MEN1CYP1A2KMT2ACARM1PRMT6
SCHEMBL7027370 0.76 CARM1 (0.48) HTR2AKCNH2MAOBMAOACACNA1G
SCHEMBL7029919 0.74 KMT2A (0.47) MEN1KMT2AHTR2AKCNH2MAOB
SCHEMBL7032862 0.74 HRH3 (0.47) KMT2AHTR2AGRM2OPRK1KCNH2
SCHEMBL7032730 0.73 RAB9A (0.52) CYP1A2GRM2KCNH2
SCHEMBL7026523 0.70 HTR1A (0.40) MEN1KMT2AHTR2AOPRK1KCNH2
SCHEMBL3589864 0.70 MAOA (0.52) HTR2AGRM2KCNH2MAOBMAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030130287-A1 Piperidine and piperazine derivatives which function as 5-ht2a receptor antagonists MERCK PATENT GMBH (DE) 2003-07-10 US disclosed
EP-1246803-A1 PIPERIDINE AND PIPERAZINE DERIVATIVES WHICH FUNCTION AS 5-HT 2A? RECEPTOR ANTAGONISTS MERCK PATENT GmbH (DE) 2002-10-09 EP disclosed
WO-2001051469-A1 PIPERIDINE AND PIPERAZINE DERIVATIVES WHICH FUNCTION AS 5-HT2A RECEPTOR ANTAGONISTS MERCK PATENT GMBH (DE) 2001-07-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030130287-A1 Piperidine and piperazine derivatives which function as 5-ht2a receptor antagonists HTR2A, HTR1A, HTR5A MEN1 3253/4885CYP1A2 591/4885KMT2A 472/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.